109 results
Page 3 of 6
6-K
EX-99.1
k1ed1jr9
23 Mar 21
Current Report
7:54am
6-K
EX-99.1
gv9 3x4q8
22 Mar 21
BiondVax Pharmaceuticals Ltd Company Presentation BiondVax Pharmaceuticals Ltd. | Jerusalem, Israel | www.biondvax.com www.biondvax.com March 2021
3:43pm
6-K
EX-99.1
g3np zfvzc4u0hd5o8
11 Feb 21
BiondVax Announces Exercise in Full of Underwriter’s Over-Allotment Option in Follow-on Offering
6:30am
6-K
EX-99.1
vxd0x zkgv
2 Feb 21
BiondVax Announces Closing of $12.1 Million Follow-on Underwritten Offering
4:36pm
424B5
6bazr
1 Feb 21
Prospectus supplement for primary offering
5:08pm
6-K
EX-99.1
4gdhv94o5m
29 Jan 21
BiondVax Announces Pricing of $12.1 Million Follow-on Underwritten Offering of American Depositary Shares
8:02am
424B5
gkp5voe
29 Jan 21
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
i57tbq3xl5g9
28 Jan 21
BiondVax Announces Launch of Proposed Underwritten Follow-on Offering of American Depositary Shares
9:29pm
6-K
EX-99.1
yye10vpal1
28 Jan 21
BiondVax Announces Third Quarter 2020 Financial Results & Business Update
5:25pm
6-K
EX-99.2
v0zwg m33
28 Jan 21
BiondVax Announces Third Quarter 2020 Financial Results & Business Update
5:25pm
6-K
EX-99.1
drkb8joq56fbb8r4q
21 Jan 21
BiondVax Announces Appointment of Amir Reichman as New CEO
11:00am
6-K
EX-99.1
lte frven
23 Oct 20
BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate
10:59am
6-K
EX-99.1
3g22y1snft76g9rt8o3
2 Oct 20
Condensed Interim Financial Statements
12:00am
424B5
y68qqanfnqo0gti
2 Oct 20
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
k9f0xreeuww9l
2 Oct 20
Condensed Interim Financial Statements
12:00am
6-K
EX-99.1
gx3e fxu1
2 Oct 20
BiondVax Announces At-The-Market (ATM) Equity Offering Program
12:00am
6-K
EX-99.1
bn67ye1
1 Sep 20
Report of Foreign Private Issuer
7:18am
6-K
EX-99.1
9f4nq7d18j7l9r l1c7
24 Aug 20
BiondVax Announces Second Quarter 2020 Financial Results
6:11am
6-K
EX-99.1
w8gzo1z2 6xvo
17 Aug 20
BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Clinical Trial Update
6:12am
F-3
khgiz
30 Jul 20
Shelf registration (foreign)
5:36pm